Stocktoria
Propanc Biopharma, Inc. PPCB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-06-15
Propanc Biopharma, Inc. statistics & valuation
Market cap$3.3M
P / B0.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -300.1% | -2515.8% | -4410.2% | -3255.4% | -15464.1% |
| Return on equity | -423.7% | 48.2% | 85.4% | 87.9% | 66.0% |
| Debt / equity | 0.04× | -0.11× | -0.13× | -0.31× | -0.20× |
| Current ratio | 1.50 | 0.01 | 0.01 | 0.00 | 0.00 |
Source: SEC EDGAR filings · CIK 0001517681 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.